Navigation Links
Savient Pharmaceuticals Names Kenneth J. Zuerblis Chief Financial Officer
Date:9/12/2011

>www.savient.com.

FORWARD-LOOKING STATEMENTSAll statements other than statements of historical facts included in this press release are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trends and uncertainties are in some instances beyond our control. Words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "will" and other similar expressions identify forward-looking statements, although not all forward-looking statements contain these identifying words. In particular, any statements regarding the safety and efficacy of KRYSTEXXA®, status of our KRYSTEXXA marketing efforts and additional plans related thereto, market demand and reimbursement for KRYSTEXXA, our view of the refractory chronic gout (RCG) market size based on the completion of our recent comprehensive study, and our market expansion plans including our MAA filing before the EMA are forward-looking statements. These forward-looking statements involve substantial risks and uncertainties and are based on our assessment and interpretation of the currently available data and information, current expectations, assumptions, estimates and projections about our business and the biopharmaceutical and specialty pharmaceutical industries in which we operate. Important factors that may affect our ability to achieve the matters addressed in these forward-looking statements include, but are not limited to, our ability to commercialize KRYSTEXXA; the risk that the market for KRYSTEXXA is smaller than we have anticipated; our ability to retain the personnel whom we have hired and to hire the remaining personnel necessary to complete the build out of our commercial team; our reliance on third parties to manufacture KRYSTEXXA; competition from existing therapies and therapies that are currently under development, includi
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
2. Savient Pharmaceuticals to Present at the Wedbush Securities 2011 Life Sciences Management Access Conference
3. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
4. Savient Pharmaceuticals to Hold Second Quarter 2011 Financial Results Conference Call on Thursday, August 4, 2011
5. Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency
6. Savient Pharmaceuticals Reports First Quarter 2011 Financial Results
7. Savient Pharmaceuticals Submits European Marketing Authorization Application for KRYSTEXXA®
8. Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
9. Savient Pharmaceuticals to Present Multiple Abstracts at The European League Against Rheumatism (EULAR) 2011 Annual Congress
10. Savient Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
11. Savient Pharmaceuticals to Hold First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  ResMed (NYSE: ... signed a definitive agreement to acquire Curative ... ventilation and sleep-disordered breathing medical devices and ... market reputation in China, combined with ResMed,s global leadership in sleep and ... China suffering from ...
(Date:7/30/2015)...  Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ... the t:slim® and t:flex™ Insulin Pumps, today announced ... with Dexcom, Inc. to allow the integration of ... G5 and G6 continuous glucose monitoring ("CGM") systems. ... with Dexcom,s future CGM systems is an important ...
(Date:7/30/2015)... 2015  Unichem Pharmaceuticals ( USA ), ... tablets 25 mg 1000-count bottle to the consumer level. ... due to the identification of a Clopidogrel tablet found ... The risk associated with mistakenly taking a Clopidogrel tablet ... of experiencing Clopidogrel,s side effects which include bleeding and/or ...
Breaking Medicine Technology:ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2
... the Company) (NASDAQ: HOLX ), a leading ... imaging systems and surgical products dedicated to serving the ... (Conceptus) request for an injunction barring future sales of ... and that no royalty will be due to Conceptus ...
... BASIS Science, Inc. ( www.mybasis.com ) the creators of the ... B1 band, will be demoing at the 2012 International CES ... for the first time. The dashboard has been designed as ... health and wellness. "We have designed the Basis ...
Cached Medicine Technology:Hologic Announces Denial of Conceptus' Request for Injunction in Patent Infringement Suit 2Hologic Announces Denial of Conceptus' Request for Injunction in Patent Infringement Suit 3BASIS Science to Demo Basis Band at 2012 International CES; Reveals Design of Web Dashboard 2
(Date:7/30/2015)... ... July 30, 2015 , ... ... that the latest issue of Inclusive™ magazine, its multimedia publication focused on implant ... edition of the new issue, Volume 6, Issue 2, as well as past ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... All-Star at the annual All-Stars Summit. Google Partners is the platform for search ... receive the full support and tools necessary to run successful search marketing campaigns. ...
(Date:7/30/2015)... ... 30, 2015 , ... Quintessa Medical Spa is happy to offer patients the ... designed specifically for the elimination of excess tissue under the chin, referred to as ... of Wisconsin to offer this innovative treatment. , Developed by Kythera Biopharmaceuticals, Kybella was ...
(Date:7/30/2015)... ... July 30, 2015 , ... The American Association of ... announcement of the reinstitution of National Prescription Drug Take-Back Days. The 10th event ... AM to 2:00 PM local time. On the 26th, the DEA, with the ...
(Date:7/30/2015)... , ... July 30, 2015 , ... New research finds ... Click here to read more on the Surviving Mesothelioma website. , Researchers ... in Missouri reviewed more than 12,000 cases of mesothelioma occurring between 1990 and 2010. ...
Breaking Medicine News(10 mins):Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 2Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 3Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 4Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2
... A new research finds that the number of individuals with ... double over the next generation//. The results of the study ... Neurology. ,The study highlights the significant challenge facing ... which are ill prepared to meet this impending public health ...
... the government to bring about new and effective campaigns against ... be main reason for this sudden surge in AIDS cases ... there is a phenomenal 41% increase of HIV cases which ... spend $10 million for campaigns which would address these issues ...
... Russia after quarantine measures were lifted August 2006. The incidence ... called for the culling// of 1.5 million birds. ... ,“A laboratory analysis has uncovered the H5N1 bird ... Krasnodar region,” says Aleksei Alekseyenko, an official at the country's ...
... in children may improve their smile but there is no ... study//. The study results were published in the British Journal ... their 20-year long study looked at the impact of braces ... their teeth had little positive impact on their psychological health ...
... in southern Vietnam have plummeted after tests showed that many ... media reported Monday. ,"Today we could only sell ... of a Ho Chi Minh City egg supplier, told the ... as well as prices came after the department of science ...
... used to correct alignment of teeth, do not improve ... later in life, finds a study//. ,Thousands of ... a widespread belief in the dental profession that braces ... of BBC News. ,Bill Shaw and researchers ...
Cached Medicine News:Health News:Worldwide Parkinson's Cases To Double In Next 25 Years 2Health News:Worldwide Parkinson's Cases To Double In Next 25 Years 3
Optical Urethrotome 8667 for telescope 4 mm, 0. For slitting urethral strictures under vision...
OES Pro Optical Urethrotome...
... With a 4.9mm insertion tube, ... and increases maneuverability even through strictured ... wide viewing angle of 125 in ... a large viewing area and simplifying ...
New technology in optics, processing and application. Laser-welded mechanics in stainless steel provide high safety in sterilization. Saphire windows distal and proximal, validated even for autoclavi...
Medicine Products: